Safety profile of glucokinase activator AZD1656: systematic review and meta-analysis of 23 randomised trials in diabetic and healthy volunteers with relevance to immunomodulatory therapy.
Saved in:
| Title: | Safety profile of glucokinase activator AZD1656: systematic review and meta-analysis of 23 randomised trials in diabetic and healthy volunteers with relevance to immunomodulatory therapy. |
|---|---|
| Authors: | Elsayed MM; Department of Clinical Pharmacy and Pharmacy Practice, Mansoura University, Mansoura, Egypt. moelsayed@mans.edu.eg., Abdalla MM; Department of Clinical Pharmacology, Glasgow University, Glasgow, UK. |
| Source: | Inflammopharmacology [Inflammopharmacology] 2025 Aug; Vol. 33 (8), pp. 4671-4684. Date of Electronic Publication: 2025 Jul 08. |
| Publication Type: | Journal Article; Systematic Review; Meta-Analysis |
| Journal Info: | Publisher: Birkhäuser Country of Publication: Switzerland NLM ID: 9112626 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1568-5608 (Electronic) Linking ISSN: 09254692 NLM ISO Abbreviation: Inflammopharmacology Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
